About C2C4C Ride
The 2026 C2C4C Asia Pacific cycling event, organized by Bristol Myers Squibb, will feature over 55 of the company's employees from seven nations cycling in Japan from 6-20 October in support of UICC and selected members in Asia Pacific to raise funds with the aim of accelerating the fight against cancer and facilitating a better life for cancer patients.
The inaugural C2C4C ride was held twelve years ago in the United States as Coast 2 Coast 4 Cancer. Riders in Europe joined the effort in 2016 for the Country 2 Country 4 Cancer, Japan in 2021 and Latin America in 2022 as the Continent 2 Continent 4 Cancer.
In this sixth edition, the 2026 C2C4C ride will feature over 55 Bristol Myers Squibb employees riding nearly 1,800 kilometers from 6-20 October. The 15-day event involves five teams each cycling a three-day segment. Since 2021, more than USD 830,000 has been donated to charitable organizations in Asia Pacific via the C2C4C ride.
In this 2026 edition, five teams will feature riders participating from seven countries including Australia, China, India, Japan, Republic of Korea, Singapore, and the United States. The mission of C2C4C is to raise awareness for cancer research and cancer organizations in the Asia Pacific region who are members of the UICC.
Join Us in Supporting a Beacon of Hope
Cancer is a significant challenge that touches so many lives, and the statistics can be overwhelming — just think about it, almost 10 million lives were lost to cancer in 2020 alone. It's heart-wrenching to know the pain it brings to families across the globe. That’s why we feel so passionately about supporting the Tata Memorial Hospital (TMH) and its extraordinary mission.
For over 80 years, TMH in Mumbai has stood tall as a sanctuary of hope for countless cancer patients and their loved ones. This remarkable hospital is devoted to providing compassionate, comprehensive cancer care to everyone who walks through its doors, driven by excellence in service, education, and groundbreaking research. Their commitment to world-class treatment combined with heartfelt care creates an environment where patients can truly feel supported.
Each year, more than 70,000 patients reach out to TMH for help, where they receive high-quality and evidence-based care tailored to their needs. What’s even more inspiring is that over 60% of these courageous individuals receive their treatment for free or at a subsidized cost. This is a shining example of the dedication to making equitable healthcare a reality for all, and we find hope in that mission.
Who Are the Riders
Team India's participation in the C2C4C 2026 cycling initiative is a groundbreaking milestone in our unified journey to elevate awareness and support for cancer research. With a remarkable team of 14 cyclists, comprised of passionate and dedicated individuals, we are set to embark on an inspiring adventure that symbolizes the unwavering fight against cancer.
Our involvement shines a spotlight on the global spirit of this
crucial cause, demonstrating how people from diverse backgrounds can
unite with fierce determination for a common purpose. As we navigate
through various terrains, Team India is poised to ignite inspiration
in countless hearts, fostering an indomitable spirit of hope and
resilience in the ongoing battle against cancer. Join us and be a part
of this extraordinary journey!
Together we will ride in support of Tata Memorial Hospital!
About BMS
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. For more information about Bristol Myers Squibb, visit us at bms.com/de or follow us on LinkedIn , Instagram , Twitter and YouTube .
About UICC
The Union for International Cancer Control (UICC) is the largest and oldest international cancer organization dedicated to reducing the burden of cancer around the world. Founded in 1933, UICC has more than 1,150 members in over 170 countries and territories. UICC ’ s mission is both to unite and support the cancer community in its efforts to reduce the global cancer burden, promote greater equity, and ensure that cancer control remains a priority on the global health and development agenda.
